Medience메디앙스
014100 · KOSDAQ · ₩014100 · 메디앙스
₩1,630▲ ₩45 (2.84%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩14B | ₩12B | ₩11B | ₩12B | ₩14B | ₩12B | ₩10B | ₩11B |
| Cost of sales | ₩7.3B | ₩6.3B | ₩6.4B | ₩5.6B | ₩7.1B | ₩5.8B | ₩8.1B | ₩6B |
| Gross profit | ₩6.8B | ₩5.6B | ₩4.2B | ₩6.3B | ₩6.9B | ₩6.4B | ₩2.4B | ₩5.5B |
| Operating income | −₩1.3B | ₩1.3B | ₩68M | −₩1.7B | ₩846M | −₩293M | −₩2.1B | −₩1.3B |
| Net income | −₩5.1B | ₩2.1B | −₩6B | ₩938M | ₩4.5B | −₩5.4B | −₩16B | ₩13B |
| Net income to shareholders | −₩3B | ₩2.1B | ₩319M | −₩2.3M | −₩941M | −₩5.4B | −₩6.3B | ₩2B |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₩108B | ₩113B | ₩109B | ₩108B | ₩106B | ₩108B | ₩113B | ₩115B |
| Current assets | ₩23B | ₩25B | ₩23B | ₩24B | ₩24B | ₩25B | ₩24B | ₩23B |
| Cash and equivalents | ₩695M | ₩1.5B | ₩3.3B | ₩3.2B | ₩3.4B | ₩4.1B | ₩4.8B | ₩2.9B |
| Total liabilities | ₩40B | ₩42B | ₩41B | ₩41B | ₩39B | ₩40B | ₩39B | ₩35B |
| Current liabilities | ₩30B | ₩32B | ₩31B | ₩31B | ₩29B | ₩31B | ₩30B | ₩26B |
| Borrowings | ₩17B | ₩17B | ₩16B | ₩16B | ₩16B | ₩17B | ₩16B | ₩19B |
| Total equity | ₩68B | ₩70B | ₩68B | ₩67B | ₩67B | ₩68B | ₩74B | ₩80B |
| Shareholders' equity | ₩68B | ₩70B | ₩68B | ₩67B | ₩67B | ₩68B | ₩74B | ₩80B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | ₩827M | −₩1.4B | ₩865M | ₩764M | ₩62M | −₩1.7B | ₩4.6B | ₩819M |
| Capital spending | ₩7.4M | ₩85M | ₩495M | ₩15M | ₩25M | ₩22M | ₩5.6M | ₩186M |
| Free cash flow | ₩819M | −₩1.4B | ₩370M | ₩749M | ₩37M | −₩1.7B | ₩4.6B | ₩634M |
Consolidated where available. Amounts in won.
Also known as: Medience / 메디앙스 / 014100 / KRX:014100
Source: KRX statistical information